DA
Therapeutic Areas
SenzaGen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GARD®skin | Skin Sensitization Hazard Identification | Commercial/Validated |
| GARD®skin Dose-Response | Skin Sensitization Potency Assessment | Commercial/Development |
| GARD®air | Respiratory Sensitization | Research & Development |
| GARD®potency | Skin Sensitization Potency Subclassification | Validated/Commercial |
| Medical Device Testing Services | Biological Safety Assessment | Commercial |